Plus, news about Ocular Therapeutix, Kardigan, ARS Pharmaceuticals, Full-Life Technologies, Orion, Novo Nordisk, Nxera Pharma and UniQure:
📈 Barinthus Biotherapeutics inks reverse merger: The UK biotech will hand its Nasdaq spot to
↧